Pfizer

•

チャンネル • 6個の番組

生命科学

生命科学

アップデート：毎週
生命科学

生命科学

2023/11/21
SF

SF

シリーズ
医学

医学

2024/12/04
教育

教育

6月16日
生命科学

生命科学

2024/11/19

4月16日 · ボーナス

Live from SXSW - How to Leverage Digital Tools to Become an Empowered Patient

Over the last five years, the healthcare industry has witnessed an explosive surge in digital health services, revolutionizing the way we access medical care. Patients today are taking charge of their health journey by using different digital tools to stay on top of their preventative screenings, implement dietary and lifestyle changes, access mental health resources, and so much more. In this conversation, patient advocates and industry leaders from Noom, Thrive, and Pfizer, dive into the potential power of artificial intelligence and the anticipated transformation in personalized health plans. They share real-world examples that highlight how digital technologies are helping patients feel empowered and shape the future of healthcare.  Through this conversation you heard Lidia Fonseca reference Health Answers by Pfizer. In February 2025, the Pfizer team launched this new platform, powered by generative AI that provides clear, relevant answers to your health & wellness questions and helps you take action for yourself and your loved ones. To learn more, visit healthanswers.pfizer.com. Moderator: Stephanie Agresta, Managing Director, Ascendancy Events  Featured experts: -Karin Bilich, Head of Content, Noom  -Lidia Fonseca, Chief Digital & Technology Officer, Pfizer  -MT Grant, SVP & GM, Thrive for Health This episode was recorded live in Austin, TX on Monday, March 10, as part of Pfizer’s takeover of the South by Southwest podcasting lounge. Please fill out our short survey so we can get to know our listeners better: pfizer.com/podcastsurvey

4月16日 · ボーナス

•

59分
2022/11/10 · ボーナス

menopause: unmuted: A Strong Menopause with Susan Niebergall

In this bonus episode, host Dr. Mary Jane Minkin sits down with online strength coach Susan Niebergall to talk about fitness, particularly strength training, and how it helps support women in midlife. Susan explains ways in which strength and resistance training can help improve muscle mass and bone density and why this is particularly important for women during perimenopause and menopause. She highlights her holistic approach to fitness, “our priority should be leading a functional life for as long as we can” and shares practical guidance for women to begin implementing strength training into their fitness routine, including while at-home. Dr. Minkin and Susan also chat about their own personal fitness journeys and finding confidence in the gym in midlife. About Susan Niebergall: Susan is a personal trainer and online strength coach with a background of over three decades in education. She shares practical guidance, tips, and demonstrations on fitness and weight training to her sizable online audience (@susanniebergallfitness) and also offers personalized coaching plans. She is also the author of Fit At Any Age: It’s Never Too Late and hosts her own podcast, Strong and Lean at Any Age. At 62 years of age, Susan is passionate about inspiring other women in midlife to get fit, often promoting her motto: “it’s never too late.” menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option. Useful Links: Susan’s Instagram: https://www.instagram.com/susanniebergallfitness/ Susan’s Website: https://susanniebergallfitness.com/ _______________ Women's Health is your destination for compelling, stand-out series that touch on all aspects of women's health. While each series may focus on a different topic, they're united in their commitment to candid conversations that destigmatize women's health issues and highlight real life people. Learn more about each series featured below: menopause: unmuted is honest, hopeful, life-affirming, and features real women talking candidly about their menopause, and its impact on relationships, friends, family, and work. Each episode shares deeply personal accounts of the different emotional and physical symptoms experienced. Our host, leading women’s health expert Dr. Mary Jane Minkin, provides an expert perspective, busting myths and offering evidence-based information. These podcasts are not designed to provide medical advice or promote or recommend any treatment option. This podcast feed is powered by Pfizer.

2022/11/10 · ボーナス

•

24分
2022/10/27

Part 1: Breast Cancer: The Science, The Challenges, The Solutions

Oncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer. Featured Guests: Martha Carlson, Breast Cancer Advocate & WriterDr. Edith Mitchell, Medical Oncologist, Thomas Jefferson UniversityJeff Settleman, Chief Scientific Officer, Pfizer Oncology

2022/10/27

•

31分
2022/10/27

Part 2: Clinical Trials: Bringing Research to Life

In part two of this series, Adam Rutherford and guests break down the next step in how potential breast cancer treatments move forward from the lab. What role do clinical trials play in the development of potential treatments? How are clinical trials developed? How can patients access clinical trials? And how are researchers and advocacy groups working to break down barriers in access to clinical trials? Featured Guests: Laurie, Breast Cancer Clinical Trial ParticipantDr. Edith Mitchell, Medical Oncologist, Thomas Jefferson UniversityJulia Perkins Smith, Global Clinical Lead, PfizerJamil Rivers, CEO, Chrysalis InitiativeAdditional Resources: pfizerclinicaltrials.com/oncologypfizerclinicaltrials.compfizerestudiosclinicos.com

2022/10/27

•

29分
2023/11/21

Part 2 – The Power of Data and Artificial Intelligence

Artificial intelligence could be an essential tool in the fight against antibiotic resistant bacteria – and data is a key part of developing that tool. In part two of this four-part series, expert guests break down the mechanics behind artificial intelligence and machine learning. As host Jeremiah Owyang traces the evolution of these tools in healthcare, he highlights the crucial role of data for understanding the problem of antibiotic resistance. Featured Guests: Adrian Egli, Director, Institute of Medical Microbiology, University of ZurichRanjit Kumble, Vice President of Enterprise Data Science and Advanced Analytics, PfizerMarinka Zitnik, Assistant Professor, Department of Biomedical Informatics, Harvard Medical School; Co-founder, Therapeutics Data Commons Season 3 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network.

2023/11/21

•

30分
2024/04/18 · ボーナス

Live from SXSW - Moonshot Culture: Innovating to Outdo Yesterday

Throughout history, humans have coalesced around moonshot culture to achieve audacious goals—from eradicating smallpox, to sequencing the human genome, to landing a spacecraft on Mars. These feats of human ingenuity didn’t happen in a vacuum, they were born from intentional innovation, a “coalition of the willing,” and a vision to outdo yesterday. This fireside chat with Drew Panayiotou, Former CMO of Pfizer and Devon Still, ex-NFL player and founder of Still Strong Foundation, explores innovations in cancer, their personal experiences with family members needing healthcare treatment, and what it will take to achieve Pfizer's next big moonshot to outdo cancer and achieve its vision, a world where people with cancer live better and longer lives. This episode was recorded live in Austin, TX on Monday March 11 as part of Pfizer’s takeover of the South by Southwest podcasting lounge. The Let's Outdo Cancer Campaign aims to focus on advances in fighting against cancer. To learn more, visit letsoutdocancer.com.

2024/04/18 · ボーナス

•

50分
2月25日

Part 3 – How Computers Learn to Think Like Scientists

With a trove of data and powerful hardware to process it, software is the last element of our artificial intelligence story. In this episode, host Jeremiah Owyang and expert guests explore the history of advancement behind the software that powers AI today. They delve into the creation of neural networks at the heart of this technology and how scientists are partnering with AI to revolutionize the complex process of drug development and discovery. Featured Guests: –Beth Cimini, Associate Director for Bio image Analysis at the Broad Institute in Cambridge, Massachusetts –Charlotte Allerton, Head of Preclinical and Translational Sciences at Pfizer –Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer –Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network.

2月25日

•

24分
2023/11/21 · ボーナス

Spill the tea on RSV: What you need to know

Respiratory Syncytial Virus (RSV) is a common virus that causes respiratory illness. For many people, RSV can be mild and presents symptoms similar to the common cold. But for certain groups, RSV can be serious, especially for babies 0 through 6 months old. In this bonus episode of The Antigen, Board-certified pediatrician Dr. Mona Amin explains the dangers of RSV in babies. Mom, reality television star, and businesswoman Catherine Guidici Lowe also joins the podcast to talk about her experience with her son contracting the virus.

2023/11/21 · ボーナス

•

9分
2024/11/19

The vital role of immunisation for disease prevention

Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS. PP-UNP-GBR-10718 / November 2024

2024/11/19

•

34分
3月4日

Part 4 – New Frontiers in AI & Drug Discovery

So far in this season, we’ve explored how innovations throughout history have brought us to where we are now. We talked about how drug discovery changed from a serendipity-based to data-based endeavor. Then, we explored the powerful hardware and smart software required to accommodate big data. Now, the door to the future of AI in drug discovery is open. In our final episode, we’re looking toward the future, to understand where today’s advancements could potentially take us. Featured Guests: –Charlotte Allerton, Head of Preclinical and Translational Sciences at Pfizer –Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer –Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer –Dr. Raza Ali, group leader at the University of Cambridge Cancer Research UK Institute, pathologist Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network.

3月4日

•

24分

Go behind the breakthroughs and explore the stories of the work we do at Pfizer around the globe, in conversations with the scientists and leaders who make it happen. Listen to recent episodes and follow along.